Allergy and Immunology · Metairie, LA
NPI
1902197403
Since 2011
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3225 Danny Park Ste 100
Metairie, LA, 70002
Phone (504) 889-0550
Medicare paid, 2024
$60K
2,394 services
Medicare patients, 2024
57
Average age 69
Drug cost, 2024
$565K
632 prescriptions
Company payments, 2025
$323
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sweta S Shah was code 99213 (office e&m - established), 29 times for 24 patients. In total Sweta S Shah billed 2,394 services in 22 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 29 | 24 | $61.10 | $1,772 |
| 99214 Office E&M - Established | Office | 22 | 15 | $92.69 | $2,039 |
By year: 2022 $95K for 3,862 services; 2023 $105K for 4,429 services; 2024 $60K for 2,394 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sweta S Shah prescribed most often to Medicare patients was Levocetirizine Dihydrochloride, with 83 prescriptions and refills. In total Sweta S Shah wrote 632 Medicare prescriptions that cost $565K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levocetirizine Dihydrochloride Generic | 83 | 145 | 24 | $843 |
| Dupixent Syringe Dupilumab | 74 | 75 | Under 11 | $287K |
| Fluticasone Propionate Generic | 62 | 87 | 18 | $770 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 52 | 72 | 12 | $46K |
| Montelukast Sodium Generic | 45 | 75 | Under 11 | $270 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 44 | 47 | 21 | $908 |
| Famotidine Generic | 28 | 42 | Under 11 | $407 |
| Epinephrine Generic | 27 | 27 | 26 | $6,654 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 21 | 21 | Under 11 | $2,163 |
| Breo Ellipta Fluticasone/Vilanterol | 16 | 16 | Under 11 | $6,171 |
| Symbicort Budesonide/Formoterol Fumarate | 15 | 15 | Under 11 | $3,458 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 14 | 14 | Under 11 | $24K |
| Gammagard S-D Immun Glob G/Gly/Gluc/Iga 0-50 | 12 | 12 | Under 11 | $110K |
Brand drugs: 283 claims; generic drugs: 349 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sweta S Shah $323 ($323 in general payments such as food, travel and fees) from 8 companies. The largest payer was CSL Behring with $77.81.
| Company | Payments | Amount |
|---|---|---|
| CSL Behring CSL.AX | 3 | $77.81 |
| Genzyme Corporation SNY | 2 | $56.47 |
| Regeneron Healthcare Solutions, Inc. REGN | 2 | $55.89 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $44.06 |
| Lilly USA, LLC LLY | 1 | $27 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 1 | $26.02 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $18.4 |
| Grifols USA, LLC | 1 | $17.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.